Lyrica 50 mg/1 (Pregabalin CAPSULE) 50 mg/1

Pregabalin works by binding to the α2δ subunit of voltage-gated calcium channels, reducing calcium influx into nerve cells. This action decreases the release of excitatory neurotransmitters, thereby calming overactive nerves and reducing pain signals. This mechanism makes it effective in managing neuropathic pain and certain types of seizures.

The usual dose of Lyrica 50 mg/1 is determined by a healthcare professional based on the patient's condition and response to treatment. It is important to follow the prescribed dosage and not to adjust it without medical advice. The dosage may vary depending on the specific condition being treated and the patient's individual needs.

Lyrica 50 mg/1 is classified as a pregnancy category C drug, meaning it should be used with caution during pregnancy. It is important to discuss the potential risks and benefits with a healthcare professional. The safety of Lyrica during breastfeeding has not been established, and it is recommended to consult a healthcare provider before using it while breastfeeding.

To order Lyrica 50 mg/1 from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will reply with pricing, availability, shipping, and the necessary import paperwork.

Lyrica 50 mg/1 is one of the most effective medications for managing neuropathic pain. It is often compared to other anticonvulsants and analgesics. Its unique mechanism of action makes it a preferred choice for conditions like diabetic peripheral neuropathy and postherpetic neuralgia. However, the choice of medication depends on individual patient needs and response to treatment.

Lyrica 50 mg/1 should be stored below 25°C, in the original pack, and protected from moisture. It is important to keep the medication out of reach of children and to follow the storage instructions provided on the packaging. Proper storage ensures the effectiveness and safety of the medication.

Lyrica 50 mg/1 is administered orally, typically in capsule form. It can be taken with or without food, as food does not significantly affect its absorption. The capsules should be swallowed whole with a glass of water. The dosage and frequency of administration are determined by a healthcare professional based on the patient's condition and response to treatment.

The most serious risks associated with Lyrica 50 mg/1 include angioedema, suicidal thoughts, and visual disturbances. Patients should be monitored for signs of severe allergic reactions, changes in mood or behavior, and any visual changes. Immediate medical attention should be sought if any of these serious side effects occur.

Lyrica 50 mg/1 should not be used by individuals who are allergic to Pregabalin or any of its ingredients. It should be used with caution in patients with a history of heart disease, kidney disease, or a tendency for suicidal thoughts. Pregnant women and breastfeeding mothers should consult a healthcare professional before using Lyrica 50 mg/1.